Which is more creative, the arts or the sciences? — ScienceDaily

International expert in creativity and innovation, UniSA’s Professor David Cropley, is calling for Australian schools and universities to increase their emphasis on teaching creativity, as new research shows it is a core competency across all disciplines and critical for ensuring future job success.

Conducted in partnership with visiting PhD researcher Kim van Broekhoven from Maastricht University in the Netherlands, the research explores the nature of creativity in determining if specific differences exist between creativity in the sciences and creativity in the arts.

The researchers found that creativity in science, technology, engineering and mathematics (STEM) is very similar to creativity in the arts, indicating that a holistic approach to teaching creativity in schools and universities, would benefit all.

UniSA’s Professor David Cropley says the study provides a valuable insight into how education systems might assess and foster students’ creative capabilities.

“The big change for education systems would be moving away from

Read More

Three Things We’ve Learnt From This Year’s Nobel Awards In The Sciences

While coronavirus will undoubtedly be the first thing people remember about 2020, the prominent role of science in society won’t be far behind – as I’ve written about previously.

And so it was with this year’s Nobel Prize announcements in the sciences that we were reminded of some other great achievements of our time away from the race to find a vaccine, with each of them rightly gaining a good share of media attention.  

To me, three things stood out. 

1) U.K. pedigree 

Ahead of the publication of the U.K. government’s new industrial strategy – in which science and innovation are anticipated to underpin all of the main themes – we were

Read More

2020 Life Sciences Sector Report from CLSA Shows Strong Growth in Jobs, Investments and Therapeutic Pipeline in California

SAN FRANCISCO, SACRAMENTO, SAN DIEGO, Calif. & WASHINGTON–(BUSINESS WIRE)–Oct 7, 2020–

California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today released the 2020 California Life Sciences Sector Report, which shows that California’s life sciences sector directly employed 323,723 people, generated $191.6 billion in revenue, is projected to attract $6.5 billion in venture capital (VC) and received $4.5 billion in funding from the NIH. Produced with PwC US, the 2020 snapshot highlights the strength of California’s biomedical sector – the largest cluster in the world – as evidenced by significant increases in employment, earnings, graduating science and engineering PhDs, VC investment, and potential new drugs and medical devices in the pipeline.

Key Highlights from 2020 California Life Sciences Sector Report

  • 4.0% increase in total life sciences jobs (up more than 12,000 from prior year), with companies directly employing 323,723 Californians – the most in
Read More

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

  •  Initiating clinical trials to evaluate investigational toll-like receptor 9 agonist, SD-101, in patients with uveal melanoma liver metastases followed by three additional indications.

  • Aspiring to overcome the challenges of treating patients with solid tumors through our multi-pronged approach to stimulate the immune system and deliver immuno-oncology therapies directly to the site of the disease, with the goal of improving the therapeutic index

  • Working to redefine the treatment of hard-to-treat solid tumors in the liver or pancreas by combining TriSalus’ proprietary FDA cleared intravascular, regional drug delivery technology for liver and pancreatic infusion with investigational SD-101 and standard of care therapy

TriSalus Life Sciences (TriSalus), an emerging immuno-oncology company committed to transforming outcomes for patients with solid tumors, announced today its therapeutic clinical development strategy following the successful acquisition of SD-101, an investigational IND-ready immunotherapy, from Dynavax Technologies on August 3, 2020.

SD-101 is an investigational toll-like receptor 9 (TLR9) agonist

Read More

David Whiting Named President of Comerica Bank’s Technology and Life Sciences Division

DALLAS, Sept. 22, 2020 /PRNewswire/ — Comerica Incorporated (NYSE: CMA) announced that David Whiting, Senior Managing Director of Technology and Life Sciences (TLS) Division, has been named President, TLS Division. In his role, Whiting will manage Comerica’s TLS teams in California, Massachusetts, New York, Texas, Virginia, Washington and Toronto, Canada.

Whiting, a 17-year veteran of Comerica, has served in various leadership roles within the TLS Division during his tenure. Most recently, he directed all TLS Division U.S. offices outside of California. For more than a decade he led the Dallas TLS team, as well as oversaw the Upper Midwest market, lending to venture-backed technology in various life cycles. He also has served in operating and finance capacities with a software company, as well as roles serving the lending needs of technology companies with Imperial Bank.  

“We look forward to leveraging David’s experience

Read More